The present study was aimed at investigating whether imatinib pharmacogenetics is related to its pharmacodynamics in patients affected by chronic myeloid leukemia.
Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia
FAVA, Carmen;D'AVOLIO, ANTONIO;SAGLIO, Giuseppe;
2017-01-01
Abstract
The present study was aimed at investigating whether imatinib pharmacogenetics is related to its pharmacodynamics in patients affected by chronic myeloid leukemia.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
art%3A10.1007%2Fs00280-017-3271-3.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
688.66 kB
Formato
Adobe PDF
|
688.66 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
